HCA Healthcare Inc
- HCA Healthcare Inc. gained 0.02% to $328.00 after the hospital and clinic operator reported first-quarter 2025 results.
Revenue edged up to $18.32 billion from $17.34 billion, net income jumped to $1.61 billion from $1.59 billion, and diluted earnings per share rose to $6.45 from $5.93 a year ago.
The company announced a quarterly cash dividend of 72 cents per share, payable on June 30 to shareholders on record as of June 16.
During the first quarter, the healthcare company repurchased 7.762 million shares at a cost of $2.506 billion, and as of March 31, it had $8.259 billion remaining under repurchase authorization.
Apr 28, 2025 - HCA Healthcare Inc. fell 1.4% to $226.95, and the hospital chain operator reported mixed quarterly results.
Revenue in the third quarter increased to $16.2 billion from $14.97 billion, net income attributable to shareholders decreased to $1.08 billion from $1.13 billion, and diluted earnings per share were flat at $3.91 compared to a year ago.
Same-facility admissions increased 3.4%, emergency room visits rose 3.5%, inpatient surgeries inched up 1.6%, and outpatient surgeries edged up 0.9%.
Same facility revenue per equivalent admission advanced 3.6% from the year-ago period.
The company announced a quarterly cash dividend of 60 cents per share payable on December 28 to share shareholders on record on December 14.
The company revised its 2023 revenue guidance to between $63.5 billion and $64.5 billion from the previous range of between $63.25 billion and $64.75 billion.
HCA tightened its range for net income attributable to shareholders between $4.94 billion and $5.13 billion from the previous range between $4.90 and $5.255 billion.
HCA also narrowed its diluted earnings per share range to between $17.80 and $18.50 from the previous guidance between $17.70 and $18.90.
Oct 25, 2023 - HCA Healthcare Inc increased 5.1% to $284.67 after the hospital operator reported quarterly results that exceeded expectations.
Revenue in the first quarter increased 3% to $15.6 billion from $14.95 billion and net income edged up to $1.54 billion from $1.46 billion and diluted earnings per share advanced to $4.85 from $4.14 a year ago.
The company lifted its full-year revenue range between $62.5 billion and $64.5 billion from the previous outlook to between $61.5 billion and $63.5 billion.
Net income range was revised higher to between $4.76 billion and $5.16 billion from $4.525 billion and $4.895 billion.
Earnings per share range was revised higher to between $17.25 and $18.55 from the previous outlook between $16.40 and $17.60.
Apr 21, 2023
| Year | Mar | Jun | Sep | Dec | Annual | |
|---|---|---|---|---|---|---|
| 2023 | 4.85 | 4.29 | 3.91 | - | - | |
| 2022 | 4.14 | 3.9 | 3.91 | 7.20 | - | |
| 2021 | 4.14 | 4.36 | 7 | 5.75 | 21.25 | |
| 2020 | 1.69 | 3.16 | 1.95 | 4.13 | 10.93 | |
| 2019 | 2.97 | 2.25 | 1.76 | 3.09 | 10.07 | |
| 2018 | 3.18 | 2.31 | 2.15 | 3.02 | 10.66 | |
| 2017 | 1.74 | 1.75 | 1.21 | 2.12 | 6.82 | |
| 2016 | 1.71 | 1.66 | 1.61 | 1.89 | 6.87 | |
| 2015 | 1.35 | 1.37 | 1.17 | 1.69 | 5.58 | |
| 2014 | 0.76 | 1.07 | 1.16 | 1.17 | 4.16 | |
| 2013 | 0.74 | 0.91 | 0.79 | 0.93 | 3.37 | |
| 2012 | 1.18 | 0.85 | 0.78 | 0.68 | 3.49 | |
| 2011 | 0.52 | 0.43 | 0.11 | 3.91 | 4.97 | |
| 2010 | 0.89 | 0.67 | 0.55 | 0.65 | 2.76 | |
| 2009 | 0.00 | 2.96 | 2.04 | -2.56 | 2.44 | |
| 2008 | 0.00 | 0.00 | 0.00 | 0.00 | 7.04 | |
| 2007 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | |
| 2006 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | |
| 2005 | 0.95 | 0.90 | 0.62 | 0.00 | 0 |